Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis

SINCE 1960 evidence has accumulated that the serum of many patients with myasthenia gravis contains globulins which may be autoantibodies. The serum globulin of up to 68% of myasthenic patients has been found by the immunofluorescence method to bind with cross striations of skeletal muscles in vitrol-3 and in vivo,2-6 with nuclei of various cells," and with thymic epithelial cells: which were later found to be myoid cells.9 Serum globulin of myasthenic patients has been demonstrated to react with ribonucleoprotein,2~3 saline extract of skeletal muscle,lO and denatured desoxyribonucleic acid.11 Immunological studies in patients with myasthenia gravis have focused mainly on the properties of the serum; however, it has not been proved that the serum globulin plays a role in the pathophysiology of this disease.12J3 It has become increasingly clear that cellular elements, particularly lymphocytes, play a role in immunological processes which may or may not be accompanied by humoral antibody. The immunological activities of lymphocytes of patients with myasthenia gravis have been studied by only a few inve~t igators . l~-~~ The present report describes studies on the immunological and biological activities of lymphocytes of the blood and other tissues from patients with myasthenia gravis and from normal subjects. The results indicate that the circulating lymphocytes and lymphoid cells of the lymph nodes and spleen of myasthenic patients produce stronger graft-versus-host reactions than similar cells from normal subjects and that lymphoid cells of the thymus of myasthenic patients with lymphoid hyperplasia do not have such activity.

[1]  D. Grob,et al.  Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission , 1969, Neurology.

[2]  D. Grob,et al.  Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission. , 1968, Neurology.

[3]  D. Grob,et al.  Myasthenia gravis. Serum globulin bound in vivo to skeletal muscle striations. , 1967, Archives of neurology.

[4]  D. Grob,et al.  Complement fixing and tissue binding serum globulins in patients with myasthenia gravis, and their relation to muscle ribonucleoprotein. , 1967, The Journal of laboratory and clinical medicine.

[5]  J. Houseley,et al.  Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis. , 1967, British medical journal.

[6]  W. Donnelly,et al.  Rectal reaction to injected ulcerative colitis leucocytes and plasma. , 1967, Gut.

[7]  B. Kakulas In vitro Destruction of Skeletal Muscle By Sensitized Cells , 1966, Nature.

[8]  R. A. Mcbride Graft-versus-host reaction in lymphoid proliferation. , 1966, Cancer research.

[9]  B. Kakulas Destruction of differentiated muscle cultures by sensitised lymphoid cells. , 1966, The Journal of pathology and bacteriology.

[10]  D. Grob,et al.  AUTOANTIBODIES AND MYASTHENIA GRAVIS, WITH SPECIAL REFERENCE TO MUSCLE RIBONUCLEOPROTEIN * , 1966, Annals of the New York Academy of Sciences.

[11]  G. Fazekas,et al.  DIRECT FLUORESCENT ANTIBODY STUDIES OF GAMMA GLOBULIN LOCALIZATION IN MUSCLE OF PATIENTS WITH MYASTHENIA GRAVIS * , 1966, Annals of the New York Academy of Sciences.

[12]  M. Cooper,et al.  THE ROLE OF THE THYMUS IN IMMUNE PROCESS * , 1966, Annals of the New York Academy of Sciences.

[13]  J. Turk,et al.  Immunological Significance of Lysosomes within Lymphocytes in vivo , 1965, Nature.

[14]  P. Kornfeld,et al.  STUDIES IN MYASTHENIA GRAVIS. IMMUNOLOGIC RESPONSE IN THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS. , 1965, Annals of internal medicine.

[15]  E. Möller ANTAGONISTIC EFFECTS OF HUMORAL ISOANTIBODIES ON THE IN VITRO CYTOTOXICITY OF IMMUNE LYMPHOID CELLS , 1965, The Journal of experimental medicine.

[16]  J. Hess,et al.  Myasthenia Gravis: Studies on in Vivo Binding of ?-Globulin to Muscle , 1965 .

[17]  L. Mallucci,et al.  LYSOSOMES IN DIVIDING CELLS, WITH SPECIAL REFERENCE TO LYMPHOCYTES. , 1964, Lancet.

[18]  H. Oosterhuis,et al.  Reactivity of Myasthenia Gravis Serum γ-Globulin with Skeletal Muscle and Thymus Demonstrated by Immunofluoirescence.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  A. Coulson,et al.  SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD. , 1964, Lancet.

[20]  H. Goodman,et al.  Antibodies in Systemic Lupus Erythematosus and Myasthenia Gravis Which React with Thermally Denatured DNA-Coated Bentonite , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[21]  P. Perlmann,et al.  In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells. , 1963 .

[22]  C. Wennersten,et al.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS IN RATS WITH LIVING LYMPHOID CELLS OF SENSITIZED DONORS. , 1963, International archives of allergy and applied immunology.

[23]  A. Marshall,et al.  The autoimmune response in myasthenia gravis. , 1962, Lancet.

[24]  E. Hess,et al.  TRANSFER OF AN AUTOIMMUNE NEPHROSIS IN THE RAT BY MEANS OF LYMPH NODE CELLS , 1962, The Journal of experimental medicine.

[25]  N. Nisbet,et al.  Runt disease. , 1962, British medical journal.

[26]  B. Seegal,et al.  Immunofluorescence Demonstration of a Muscle Binding, Complement-Fixing Serum Globulin Fraction in Myasthenia Gravis. ∗ , 1960 .

[27]  G. Siskind,et al.  STUDIES ON THE RUNTING SYNDROME IN NEWBORN MICE , 1959, Journal of Experimental Medicine.

[28]  D. Grob,et al.  Myasthenia gravis: current status of pathogenesis, clinical manifestations, and management. , 1958, Journal of chronic diseases.